Medullary thyroid cancer: options for systemic therapy of metastatic disease?
- PMID: 16549818
- DOI: 10.1200/JCO.2005.05.4106
Medullary thyroid cancer: options for systemic therapy of metastatic disease?
Comment on
- 
  
  Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.J Clin Oncol. 2006 Apr 10;24(11):1705-11. doi: 10.1200/JCO.2005.04.4917. Epub 2006 Mar 20. J Clin Oncol. 2006. PMID: 16549819 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        